Jablonski Anita, Gift Audrey, Cook Kathleen E
Seattle University, WA 98122-1090, USA.
West J Nurs Res. 2007 Nov;29(7):845-63. doi: 10.1177/0193945906296547. Epub 2007 Jun 4.
The primary purpose of this secondary data analysis was to evaluate the efficacy and suitability of the Memorial Symptom Assessment Scale (MSAS) for use with patients with severe chronic obstructive pulmonary disease (COPD). Symptoms experienced by patients with severe COPD were assessed in the original investigation using the 32-item MSAS. The sample consisted of 72 individuals with COPD ranging in age from 36 to 79 years. To increase its efficiency for use with severely ill COPD patients, the original MSAS was shortened to include the 19 most frequently reported symptoms. Reliability of the revised tool remained high (Cronbach's alpha = .86). Content and convergent validity of the revised tool were also established. The revised MSAS appears to be an appropriate measure of the multidimensional, multisymptom experience of patients with severe COPD.
本次二次数据分析的主要目的是评估纪念症状评估量表（MSAS）用于重度慢性阻塞性肺疾病（COPD）患者的有效性和适用性。在最初的调查中，使用包含32个条目的MSAS对重度COPD患者所经历的症状进行了评估。样本包括72名年龄在36岁至79岁之间的COPD患者。为提高其用于重症COPD患者的效率，将原始的MSAS缩短为包含19个最常报告的症状。修订后的工具可靠性仍然很高（克朗巴赫α系数 = 0.86）。还确立了修订后工具的内容效度和收敛效度。修订后的MSAS似乎是衡量重度COPD患者多维、多症状体验的合适工具。
